Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Kwaku Owusu - aVenture Research

Kwaku Owusu

AddedMar 31, 2024

UpdatedOct 15, 2026

Kwaku Owusu

Kwaku Owusu

Co-Founder & CEO, Drugviu

Kwaku Owusu's Career

Ilerasoft

Seed

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

$50k

Chicago, IL, US

Co-Founder

Drugviu

Seed$4.8MNew York City, NY, US

Co-Founder & CEO· C-Suite · Management

Co-Founder

People Similar to Kwaku Owusu

G. Cameron DeemerCEO · DrFirst.com

James ChenBoard Member · DrFirst.com

John SandersCo-Founder & CEO · DoseDr

Marlon CastilloFounder · DoseDr

Fred AshburyCo-Founder · VieCure

Lee MooneyBoard Member · DrFirst.com

Vish KulkarniCo-Founder · MediKarma

Leadership at Ilerasoft

Melanie IgweCo-Founder

Similar to Ilerasoft

UptimeHealthBoston, MA, USMedical Devices, Softwareest. 2018UptimeHealthBoston, MA, US · est. 2018

UptimeHealth: Streamlining medical device services, purchases, and compliance via automation and analytics.

Series A · $7.5M40

Operating AnalyticsCambridge, MA, USAnalytics, Softwareest. 2013Operating AnalyticsCambridge, MA, US · est. 2013

Operating Analytics optimizes hospital OR utilization with data-driven forecasts for efficient scheduling.

AgileMDSan Francisco, CA, USAnalytics, Clinical Pathwaysest. 2011AgileMDSan Francisco, CA, US · est. 2011

AgileMD: Advanced analytics & clinical protocols for enhanced hospital care.

Seed · $2.2M18

Treatment ScoresSebring, FL, USMedical Informationest. 2014Treatment ScoresSebring, FL, US · est. 2014

Florida-based Treatment Scores, Inc. empowers patients with crucial health decisions by providing evidence-based treatment rankings and references worldwide.

Leadership at Drugviu

Laura RochaCo-Founder

Jose Daniel Ramirez SotoCo-Founder

Similar to Drugviu

DrugviuHealth Data, Patient OutcomesDrugviu

Drugviu was founded with the mission to improve health outcomes for people of color by leveraging real-world data and community insights. The company focuses on creating a comprehensive health data platform that collects and analyzes patient-reported outcomes, particularly from underrepresented groups. Their core service includes a user-friendly platform where patients can share their medication experiences and health conditions, contributing to a valuable database that informs better healthcare decisions and personalized treatments. Notable affiliated individuals include co-founder and CEO Kwaku Owusu. Drugviu has attracted attention from investors interested in health tech and social impact, though specific names are not publicly disclosed. Key achievements include building a robust database that enhances healthcare providers' understanding of diverse patient populations and securing partnerships with medical institutions. The overall impact of Drugviu lies in its potential to reduce health disparities and improve the quality of care for marginalized communities.

AndHealthColumbus, OH, USHealthcare, Telemedicineest. 2021AndHealthColumbus, OH, US · est. 2021

AndHealth: A virtual center for managing migraines and reversing chronic diseases.

VivorCareSomerville, MA, USHealthcare, Wellnessest. 2021VivorCareSomerville, MA, US · est. 2021

VivorCare: A virtual clinic providing comprehensive care and community for critical illness survivors.

MymeeNew York City, NY, USRemote Careest. 2017MymeeNew York City, NY, US · est. 2017

Mymee offers remote care for chronic autoimmune diseases with 79% seeing results in 8 weeks.

Series A · $8.7M24